GM
Magliocco, Gaëlle
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Evaluation of CYP1A2 activity: Relationship between the endogenous urinary 6-hydroxymelatonin to melatonin ratio and paraxanthine to caffeine ratio in dried blood spots | Clinical and translational science |  | 2022 | 242 | 203 | ||
| Cytochrome P450 Activity Assessment: Toward Validation of Endogenous Metrics and Discovery of New Biomarkers Using Untargeted Metabolomics |  | 2022 | 706 | 33 | |||
| The 1β-Hydroxy-Deoxycholic Acid to Deoxycholic Acid Urinary Metabolic Ratio: Toward a Phenotyping of CYP3A Using an Endogenous Marker? | Journal of personalized medicine | | 2021 | 225 | 64 | ||
| Metabolomics reveals biomarkers in human urine and plasma to predict cytochrome P450 2D6 (CYP2D6) activity | British journal of pharmacology | | 2021 | 327 | 190 | ||
| The tyrosine kinase inhibitor nilotinib inhibits SARS‐CoV‐2 in vitro | Basic & Clinical Pharmacology & Toxicology | | 2021 | 233 | 2 | ||
| Simultaneous determination of melatonin and 6-hydroxymelatonin in human overnight urine by LC-MS/MS | Journal of chromatography. B | | 2021 | 434 | 474 | ||
| Modern approaches for the phenotyping of cytochrome P450 enzymes in children | Expert Review of Clinical Pharmacology | | 2020 | 214 | 1 | ||
| Interaction between Fexofenadine and CYP Phenotyping Probe Drugs in Geneva Cocktail | Journal of Personalized Medicine | | 2019 | 476 | 265 | ||
| Phenotyping of human CYP450 enzymes by endobiotics: current knowledge and methodological approaches | Clinical Pharmacokinetics | | 2019 | 425 | 3 | ||
| Toward precision medicine in pediatric population using cytochrome P450 phenotyping approaches and physiologically based pharmacokinetic modeling | Pediatric Research | | 2019 | 334 | 2 |
